DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares of the company’s stock, valued at $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
DocuSign Stock Down 2.7 %
Shares of NASDAQ:DOCU traded down $2.33 during midday trading on Monday, reaching $83.43. The company’s stock had a trading volume of 4,586,211 shares, compared to its average volume of 2,590,343. The firm has a market cap of $16.85 billion, a price-to-earnings ratio of 17.20, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The business has a 50 day moving average price of $87.97 and a 200 day moving average price of $79.52.
DocuSign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. The business had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.76 earnings per share. Sell-side analysts anticipate that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Several equities analysts recently weighed in on DOCU shares. Jefferies Financial Group raised their price objective on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. UBS Group dropped their price objective on DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a research note on Friday. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $90.00 price objective on shares of DocuSign in a research note on Friday. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Friday. Finally, William Blair raised DocuSign from a “market perform” rating to an “outperform” rating in a research note on Monday. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $95.58.
View Our Latest Research Report on DOCU
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Can TikTok Stock Picks Really Make You Rich?
- 3 Tickers Leading a Meme Stock Revival
- The “Quality” Rotation: Back to Basics Investing
- What Are Dividends? Buy the Best Dividend Stocks
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.